Freestone Capital Holdings’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,036
| Closed | -$218K | – | 445 |
|
|
2022
Q1 | $218K | Buy |
1,036
+11
| +1% | +$2.32K | 0.01% | 527 |
|
|
2021
Q4 | $246K | Buy |
1,025
+126
| +14% | +$30.2K | 0.01% | 436 |
|
|
2021
Q3 | $254K | Sell |
899
-24
| -3% | -$6.78K | 0.01% | 373 |
|
|
2021
Q2 | $320K | Sell |
923
-128
| -12% | -$44.4K | 0.02% | 328 |
|
|
2021
Q1 | $294K | Buy |
1,051
+58
| +6% | +$16.2K | 0.02% | 330 |
|
|
2020
Q4 | $243K | Sell |
993
-185
| -16% | -$45.3K | 0.01% | 323 |
|
|
2020
Q3 | $334K | Sell |
1,178
-178
| -13% | -$50.5K | 0.02% | 262 |
|
|
2020
Q2 | $363 | Sell |
1,356
-213
| -14% | -$57 | ﹤0.01% | 262 |
|
|
2020
Q1 | $496 | Sell |
1,569
-1,240
| -44% | -$392 | 0.01% | 249 |
|
|
2019
Q4 | $834 | Sell |
2,809
-1,685
| -37% | -$500 | 0.02% | 275 |
|
|
2019
Q3 | $1.05K | Sell |
4,494
-1,326
| -23% | -$309 | 0.03% | 256 |
|
|
2019
Q2 | $1.36K | Sell |
5,820
-30,245
| -84% | -$7.07K | 0.03% | 201 |
|
|
2019
Q1 | $8.53M | Buy |
36,065
+1,367
| +4% | +$323K | 0.51% | 55 |
|
|
2018
Q4 | $10.4M | Sell |
34,698
-15,269
| -31% | -$4.59M | 0.71% | 37 |
|
|
2018
Q3 | $17.7M | Buy |
49,967
+40,645
| +436% | +$14.4M | 0.11% | 28 |
|
|
2018
Q2 | $2.71M | Buy |
+9,322
| New | +$2.71M | 0.02% | 124 |
|
|
2017
Q2 | – | Sell |
-2,064
| Closed | -$564K | – | 324 |
|
|
2017
Q1 | $564K | Sell |
2,064
-258
| -11% | -$70.5K | 0.04% | 260 |
|
|
2016
Q4 | $659K | Buy |
+2,322
| New | +$659K | 0.06% | 236 |
|
|
2013
Q3 | – | Sell |
-3,544
| Closed | -$763K | – | 332 |
|
|
2013
Q2 | $763K | Buy |
+3,544
| New | +$763K | 0.16% | 114 |
|